AbbVie Inc. (4AB.DU) DUS

195.60

-0.6(-0.31%)

Updated at December 05 09:30AM

Currency In EUR

AbbVie Inc.

Address

North Chicago,

United States of America

Phone

N/A

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Employees

50000

First IPO Date

February 20, 2020

Key Executives

N/A

Description

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.